{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-036834","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2026-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.357843+00:00","generated_at":"2026-05-15T08:22:42.530484+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"DarioHealth enters $20M at-the-market equity distribution agreement with A.G.P./Alliance Global Partners","bullets":["Company may issue and sell up to $20M of common stock through ATM program with A.G.P./Alliance Global Partners.","Commission of 3.00% of gross proceeds; reimbursement of expenses up to $35,000 plus quarterly fees.","Proceeds to be used for commercial activities, R&D, M&A, corporate activities, repayment of debt, and working capital.","Shares offered under effective S-3 registration statement filed March 19, 2026, effective March 27, 2026.","Company has no obligation to sell any shares and may suspend or terminate the agreement at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-036834","json":"https://secwatch.observer/filing/0001104659-26-036834.json","markdown":"https://secwatch.observer/filing/0001104659-26-036834.md","text":"https://secwatch.observer/filing/0001104659-26-036834.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926036834/0001104659-26-036834-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926036834/tm2610107d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:22:42.530484+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1140fdb8f2e5a084cbf0fe23408a41c56ece0ec6","claim":"DarioHealth Corp. entered into Sales Agreement with A.G.P./Alliance Global Partners valued at $20,000,000 (effective 2026-03-30).","evidence_excerpt":"On March 30, 2026, DarioHealth Corp., a Delaware corporation (the “Company”), entered into a sales agreement (the “Sales Agreement”) with A.G.P./Alliance Global Partners (the “Agent”), pursuant to which the Company may issue and sell, from time to time, up to an aggregate of $20,000,000 of shares of its common stock","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465926036834/0001104659-26-036834-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners"},{"label":"Value","value":"$20,000,000"},{"label":"Effective","value":"2026-03-30"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}